Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-10
2006-01-10
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S333000, C514S334000, C514S344000, C514S352000, C546S281400, C546S193000, C546S194000, C546S257000, C546S289000, C546S311000, C546S312000
Reexamination Certificate
active
06984649
ABSTRACT:
Pyridine compounds of general formula:wherein —R1representsin which R11is hydrogen, C1-6alkyl, halogen, hydroxy, C1-12alkoxy, nitro, amino, C1-6alkylsulfonylamino, C1-6alkoxycarbonyl, C1-6alkylamino, di (C1-6alkyl)amino, C1-6alkanoylamino, phenyl C1-6alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2represents hydrogen or halogen; R3represents 1.2.3.6-tetrahydro-pyridine, or —CR31R32R33wherein R31represents H or C1-6alkyl and R32and R33are joined to form a 5-8 membered saturated ring optionally containing up to three heteroatoms; R4is carbamoyl, CN, carboxyl, etc.; R5is amino, C1-6alkylamino, di C1-6alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.
REFERENCES:
patent: 4003908 (1977-01-01), Denzel et al.
patent: 0127103 (2001-04-01), None
Nagai, W., et al., “Structures and Fluorescence of Secondary Products Produced from the Cope-Knoevenagel Reaction of 2-Phenylpropionaldehyde with Methyl Cyanoacetate”, J. Heterocyclic Chem., 33, 123-128 (1996).
Sakurai, A., et al., “The Cyclization of Ethyl Cyanoacetate and Salicylaldehyde or 3-Methoxysalicylaldehyde with Ketones by Means of Ammonium Acetate”, Bull. Chem. Soc. Japan, 43, 2925-2933 (1970).
Manna, F., et al., “Anti-inflammatory, Analgesic and Antipyretic 4,6-disubstituted 3-cyano-2-aminopyridines”, Eur. J. Med. Chem., 34, 245-254 (1999).
Chem. Abstr. 92: 163866, Takeuchi, I. et al., “Syntheses of Nitrogen-containing Heterocyclic Compounds. XXXVII. On the Antimicrobial Activity and Synthesis of 2-phenylquinoline 1-oxides and phenyl-1, 8-naphthyridines”, Yakugaku Zasshi 99, 451-457 (1979).
Manna, F., et al., “Anti-inflammatory, Analgesic and Antipyretic 4, 6-disubstituted 3-cyanopyridine-2-ones and 3-cyano-2-aminopyridines”, Eur. J. Med. Chem., 27, 627-632 (1992).
Chem. Abstr. 134: 222965, Singh, G., et al., “Synthesis of Some Novel 4-imino-3, 5, 7-trisubstituted Pyrido[2, 3- d]pyrimidine-2(1H)-thiones and Their Nucleosides as Potential Therapeutic Agents”, Phosphours, Sulfur, and Silicon, 165, 107-116 (2000).
Chem. Abstr. 126: 89234, Desai, J., et al., “Synthesis and Biological Studies of Some 2-amino-3-cyano-4-aryl-6-(2'-hydroxy-3'bromo/3'-nitro-5-'methylphenyl) Pryidines”, Oriental J. Chem., 12, 209-210 (1996).
Singh, B., et al., “Novel cAMP PDE III Inhibitors: Imidazo [4,5-b]pyridin-2(3H)-ones and Thiazolo[4,5-b]pyridin-2(3H)-ones and Their Analogs”, J. Med. Chem., 37, 248-254 (1994).
Fuchikami Kinji
Kadono Hiroshi
Komura Hiroshi
Koriyama Yuji
Lowinger Timothy B.
Bayer Aktiengesellschaft
Dentz Bernard
LandOfFree
Pyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3603472